Received Feb 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EL1234 | IM / UN |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | en9581 | IM / UN |
patient believes her covid vaccine from Pfizer contributed to her pulmonary embolisms/deep vein thombosis that occurred 3 days after the 2nd dose of the Pfizer vaccine regimen (1st dose given from lot EL1234, second dose from lot en9581, patient gave no indication she would be contacted for follow up). No other details such as dates or anything else was given.
hypertension, pulmonary fibrosis, atherosclerotic heart disease, a.fib
codeine